InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,568.63
(
0.57%
)
Post# of 648882
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

xray44b9

Send PM Follow Ignore
Followers 10
Posts 2292
Boards Moderated 0
Alias Born 01/22/2005

xray44b9

Re: DewDiligence post# 346005

Wednesday, 11/10/2010 11:58:27 PM

Wednesday, November 10, 2010 11:58:27 PM

Post# of 648882
RE ANDS --- Piper Jaffray Overweight On Anadys Pharmaceuticals (ANDS)

Piper Jaffray has an Overweight rating on Anadys Pharmaceuticals (NASDAQ: ANDS) to go along with a $3 price target on the company.

http://www.benzinga.com/analyst-ratings/analyst-color/10/11/592825/piper-jaffray-overweight-on-anadys-pharmaceuticals-ands

Stifel Nicolaus reiterated Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) to Buy with price target $3

http://www.gainerstoday.com/Article-78043

Buy low Sell high.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up